Acquires additional 36.58% stake in Lincoln Parenteral
Lincoln Pharmaceuticals announced that it has acquired 36.58% additional equity in its subsidiary, Lincoln Parenteral, taking the total investment up to 98.58%.Powered by Capital Market - Live News
